SINGAPORE, Aug. 6 (Xinhua) Singapore Ministry of Health (MOH) reported 97 new COVID-19 cases on Friday, bringing the total tally in the country to 65,605. Th
Bharat Biotech says WHO nod to Covaxin for emergency use listing soon The review process has now commenced with the expectation that we will receive EUL from WHO at the earliest, said Chairman Krishna Ella Covaxin to soon receive nod for EUL from WHO BusinessToday.In
Updated Jul 13, 2021, 9:23 AM IST
Bharat Biotech said that its coronavirus vaccine Covaxin is likely to soon get the nod from World Health Organisation for emergency use listing (EUL). The documents have been submitted by the company and the WHO is reviewing the same. All documents required for Emergency Use Listing (EUL) of Covaxin have been submitted to WHO as of 9th July. The review process has now commenced with the expectation that we will receive EUL from WHO at the earliest, said Bharat Biotech Chairman and MD Krishna Ella in a tweet.
No need for jab to be approved by WHO, says FDA
8
published : 13 May 2021 at 08:06
8
The Food and Drug Administration (FDA) has confirmed that each country has the right to register Covid-19 vaccines that will be used by their people without relying on a vaccine list approved by World Health Organisation (WHO).
Secretary-General of the FDA Paisarn Dunkum said Covid-19 vaccines approved according to the WHO Emergency Use Listing Procedure (EUL) are for use under the Covax initiative. The procedure can also be used as a reference when considering Covid-19 vaccine registration in countries with an incomplete vaccine regulatory system, he said.
2021-04-30 12:05:31 GMT2021-04-30 20:05:31(Beijing Time) Xinhua English
GENEVA, April 30 (Xinhua) The World Health Organization (WHO) will meet between this week and next week to assess the Chinese COVID-19 vaccines developed by Sinopharm and Sinovac for the WHO Emergency Use Listing Procedure, according to a WHO official and recent media reports. We do have an advisory group meeting today, and it will meet the next days to assess Sinopharm, said Mariangela Batista Galvao Simao, WHO assistant director-general for access to medicines and health products, at a briefing on Monday. We will be assessing Sinovac on May 5, she said, adding we expect that for Sinopharm we will have a decision before the end of this week, and Sinovac most likely by the end of next week.
The World Health Organization (WHO) will meet between this week and next week to assess the Chinese COVID-19 vaccines developed by Sinopharm and Sinovac for the WHO Emergency Use Listing Procedure, according to a WHO official and recent media reports. We do have an advisory group meeting today, and it will meet the next days to assess Sinopharm, said Mariangela Batista Galvao Simao, WHO assistant director-general for access to medicines and health products, at a briefing on Monday. We will be assessing Sinovac on May 5, she said, adding we expect that for Sinopharm we will have a decision before the end of this week, and Sinovac most likely by the end of next week.